Showing 5471-5480 of 5643 results for "".
- Compulink Showcases Eyecare Specific Artificial Intelligence EHR Solution at Vision Expo West 2018https://modernod.com/news/compulink-showcases-eyecare-specific-artificial-intelligence-ehr-solution-at-vision-expo-west-2018/2479838/Compulink Healthcare Solutions will demonstrate the latest enhancements to Eyecare Advantage at this week’s International Vision Expo West. This includes new artificial intelligence (AI)-enabled features in a release its calling Advantage SMART Practice. Adva
- National Industries for the Blind Announces New Strategic Alliancehttps://modernod.com/news/national-industries-for-the-blind-announces-new-strategic-alliance/2479842/National Industries for the Blind (NIB) announced a new strategic alliance with the William L. Hudson BVI Workforce Innovation Center to deliver world-class training and professional development for people who are blind. The William L. Hudson BVI Workforce Innovation Center, located in
- ASCRS Releases Preliminary CyPass Withdrawal Consensus Statementhttps://modernod.com/news/ascrs-releases-preliminary-cypass-withdrawal-consensus-statement/2479843/The American Society of Cataract and Refractive Surgery convened a CyPass Withdrawal Task Force to review the data from the COMPASS-XT study and related research and develop an independent physician guidance document associated with the voluntary withdrawal of Alcon’s CyPass Micro-Stent. To
- Neurolens Appoints Davis Corley Chief Executive Officerhttps://modernod.com/news/neurolens-appoints-davis-corley-chief-executive-officer/2479848/Neurolens announced that its board of directors has named Davis Corley chief executive officer (CEO). Mr. Corley was a co-founder of neurolens in 2012 and has served as president since 2014, a role that he will continue. “Since day one, Davis has led the dev
- Ellex 2RT Retinal Rejuvenation Effective for Select Cases of Intermediate AMDhttps://modernod.com/news/ellex-2rt-retinal-rejuvenation-effective-for-select-cases-of-intermediate-amd/2479852/Ellex Medical Lasers Limited announced the results of the Ellex 2RT Laser Intervention in Age-Related Macular Degeneration (LEAD) multicenter clinical trial. The results of the trial were published in Ophthalmology. According to researchers involved in the LEAD trial, Ellex’s 2RT
- Heidelberg Engineering Announces CE Mark Approval of Anterionhttps://modernod.com/news/heidelberg-engineering-announces-the-ce-marking-of-anterion/2479854/Heidelberg Engineering announced the CE-marking of Anterion, a platform designed to transform anterior segment diagnostics and workflow. The new Anterion provides anterior segment examinations and measurements in one modular, upgradeable platform. It is a single, workflow-efficient solutio
- Optos Launches Monaco Ultra-Widefield Retinal Imaging Systemhttps://modernod.com/news/optos-launches-monaco-ultra-widefield-retinal-imaging-system/2479855/Optos has launched Monaco, its latest ultra-widefield device to the European ophthalmic market. Monaco is the only ultra-widefield retinal imaging system with integrated Optical Coherence Tomography (OCT), according to Optos. It produces a 200° single-capture optomap image in less than hal
- MacuLogix Launches the AdaptDx in Europehttps://modernod.com/news/maculogix-launches-the-adaptdx-in-europe-at-euretina/2479856/MacuLogix will launch the AdaptDx in Europe during its debut at the European Society of Retina Specialists (EURETINA) annual congress
- Oxurion Enrolls First Patient in Phase 1 Clinical Trial Evaluating THR-687 for Treatment of DMEhttps://modernod.com/news/oxurion-enrolls-first-patient-in-phase-1-clinical-trial-evaluating-thr-687-for-treatment-of-dme/2479860/Oxurion announced the enrollment of the first patient in a phase 1 open-label, multicenter, dose escalation study evaluating the safety of a single intravitreal injection of THR-687 for the treatment of patients with diabetic macula edema (DME). THR-687 is a novel pan-RGD integrin antagoni
- Nidek Launches the GS-1 Gonioscopehttps://modernod.com/news/nidek-launches-the-gs-1-gonioscope/2479862/Nidek has announced the launch of the GS-1 Gonioscope. The GS-1 is the first automated gonioscopy device enabling 360-degree color iridocorneal angle imaging allowing more clinicians to reliably perform gonioscopy in